Patient handout: What is PROM?

Infants born preterm or with complications face higher risks of chronic conditions in adulthood, highlighting policy and health care needs.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

DiaMedica Therapeutics' investigational therapy DM199 significantly reduced blood pressure and improved uterine blood flow in patients with preeclampsia, with a favorable safety profile.

Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.

Joint recommendations highlight the importance of screening, medication management, and contraception counseling to improve pregnancy outcomes in women with diabetes.

A new study reveals distinct gut microbiota patterns in pregnant women with gestational diabetes, offering potential for early, non-invasive detection and targeted interventions.